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ABSTRACT
Background: An in vitro elicitation test employing human high-affinity IgE receptor-expressing rat mast cell
lines appears to be a useful method for measuring mast cell activation using a patient’s IgE and an allergen;
however, such cell lines are sensitive to human complements in the serum. We have recently developed a new
luciferase-reporting mast cell line (RS-ATL8) to detect IgE crosslinking-induced luciferase expression (EXiLE)
with relatively low quantities of serum IgE.
Methods: A total of 30 patients suspected of having egg white (EW) allergy were subjected to an oral food
challenge (OFC) test; then, the performances of EW-specific serum IgE (CAP-FEIA), EW-induced degranula-
tion, and EXiLE responses in RS-ATL8 cells were compared using receiver-operating characteristic (ROC)
curve analysis. The patients’ sera were diluted to 1 : 100, which causes no cytotoxicity when sensitizing the
RS-ATL8 cells for the degranulation and EXiLE tests.
Results: The area under the ROC curves was highest in the EXiLE test (0.977), followed by CAP-FEIA (0.926)
and degranulation (0.810). At an optimal cutoff range (1.648-1.876) calculated from the ROC curve of the EX-
iLE test, sensitivity and specificity were 0.944 and 0.917, respectively. A 95% positive predictive value was
given at a cutoff level of 2.054 (fold increase in luciferase expression) by logistic regression analysis.
Conclusions: In contrast to in vivo tests, the EXiLE test appears to be a useful tool in diagnosing patients
suspected of having IgE-dependent EW allergy without the risk of severe systemic reactions.
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INTRODUCTION
Oral food challenge (OFC) is a gold standard for food
allergy diagnosis, though it is accompanied by the
risk of severe allergic reactions, including anaphy-
laxis.1,2 Another in vivo test, the skin prick test, is
also known to have a slight risk of anaphylaxis.3 In vi-
tro tests, for example CAP-FEIA, often measure clini-
cally irrelevant IgE binding to allergens, such as
cross-reactive carbohydrate determinants,4,5 since
their detection sensitivity is very high. As a tool to fill
the gap between in vivo and in vitro allergy tests, the
basophil activation test (BAT) was recently estab-
lished.6,7 However, the BAT requires fresh basophils
in the patient’s blood, which cannot be preserved for
long periods.
To determine whether binding between IgE and al-
lergens would lead to mast cell activation, human
high-affinity IgE receptor (FcεRI)-expressing rat mast
cell lines (“humanized” RBL cell lines) have been de-
veloped by several groups, including ours.8-11 An in
vitro elicitation test using such humanized RBL cell
lines would seem to be useful in investigating the
properties of IgE andor allergens on the basis of
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Table　1　Profi les of the egg white allergic subjects
OFC of
boiled egg n Sex (F/M)
Age (y)
(Median; Range)
Total IgE (IU/ml)
(Geometric mean; 25-75%)
EW-specifi c IgE (UA/ml)
(Geometric mean; 25-75%)
Positive 18 8/10 7.5; 3-14  849; 536.5-1221.5 16.5; 7.26-33.8
Negative 12 3/9  10; 5-36 1685; 667.9-5244.0 1.04; 0.34-2.39
OFC, oral food challenge; EW, egg white.
mast cell activation using serum specimens. How-
ever, since these rat-derived cell lines are sensitive to
human complements, spontaneous mediator release
from these cells in the presence of human sera is not
negligible.
Recently, we have established a new humanized
RBL cell line, named RS-ATL8, by integrating nuclear
factor of activated T cells (NF-AT)-responsive firefly
luciferase reporter gene into human FcεRI-expre-
ssing RBL-SX38 cells to measure IgE crosslinking-
induced luciferase expression (EXiLE).12 In that re-
port, we showed that by taking a twofold increase in
luciferase expression as a cutoff level, EXiLE tests for
egg white (EW)-allergic subjects correlated very well
to both OFC and EW-specific IgE in the serum. Thus
far, we have investigated 30 EW-allergic subjects (18
were OFC positive and 12 were negative). In the pre-
sent study, receiver-operating characteristic (ROC)
curve analysis13,14 was performed on the EXiLE test
for EW in addition to the EW-specific IgE test (CAP-
FEIA) and EW-induced degranulation test using RS-
ATL8 cells to compare these serum IgE tests and to
calculate optimal cutoff levels.
METHODS
CELLS AND REAGENTS
A human FcεRI-expressing rat mast cell line (RS-
ATL8) was maintained in minimal essential medium
(MEM; Invitrogen, Rockville, MD, USA) supple-
mented with 10% heat-inactivated fetal calf serum
(FCS; Nichirei Biosciences, Tokyo, Japan), penicil-
linstreptomycin (Invitrogen), 1.2 mgml geneticin
(Invitrogen), and 200 μgml hygromycin (Invitro-
gen), as described previously.12 This cell line has
been stably integrated with the NF-AT-responsive
firefly luciferase reporter gene. Egg white extract
(EWE; 100 mg of freeze-dried EW powder per 1 ml in
stock solution) prepared for scratch diagnostic tests
was purchased from Torii Pharmaceutical (Tokyo, Ja-
pan) for the in vitro elicitation tests.
SUBJECTS
Patients with suspected egg allergy referred to a hos-
pital for investigation were enrolled in the study (Ta-
ble 1), as described previously.12 Most of the patients
had atopic dermatitis and asthma. Informed consent
was obtained from patients, their parents, or both to
collect and investigate serum samples further. The
study was approved by the institutional review board
of the National Institute of Health Sciences and Eth-
ics Committee of Fujita Health University School of
Medicine. All sera were collected before the food
challenge to measure total and allergen-specific IgE
levels using the CAP-FEIA system (Phadia, Uppsala,
Sweden). Every patient was subjected to double-
blind, placebo-controlled food challenges with boiled
egg in a sequential dose-escalation manner; the pa-
tient was judged positive if he or she was unable to
eat the equivalent of a whole egg due to an immediate
reaction (within 2 hours), as described previously.15
All sera were stored at -80℃.
LUCIFERASE ASSAY
RS-ATL8 cells (5 × 104 cells50 μlwell) were plated
onto a clear-bottom white 96-well plate (ViewPlate,
Perkin Elmer, Waltham, MA, USA) and incubated for
3 h at 37℃ in a 5% CO2 incubator. Then, the cells
were sensitized with 1 : 100-diluted human serum in
MEM containing 10% FCS. After overnight incuba-
tion, the cells were washed once with sterile PBS,
and then stimulated for 3 h at 37°C in a 5% CO2 incu-
bator with 0.1-1000 ngml EWE diluted in MEM con-
taining 10% FCS (50 μlwell). After stimulation, 50 μl
of luciferase substrate solution containing cell lysis
reagent (ONE-Glo, Promega, Tokyo, Japan) was
added to the cells, and chemiluminescence was meas-
ured using an EnVision multilabel plate reader
(Perkin Elmer). Luciferase expression levels were
represented as the fold increase of light units com-
pared with the background expression after subtrac-
tion of a blank control (without cells). Measurements
were done in duplicate, and the average was used for
analysis.
DEGRANULATION ASSAY
Degranulation of RS-ATL8 cells was measured using
β-hexosaminidase release as described previously
with some modifications.8,12 RS-ATL8 cells were
plated and sensitized with 1 : 100-diluted sera as de-
scribed above. After overnight incubation, the cells
were washed twice with 1,4-piperazine-bis (2-etha-
nesulfonic acid) (PIPES) buffer (140 mM NaCl, 5
mM KCl, 0.6 mM MgCl2, 1.0 mM CaCl2, 5.5 mM glu-
cose, 0.1% BSA, and 10 mM PIPES, pH 7.4). After in-
cubation for 30 min at 37℃, the supernatants were
collected, and residual cells were lysed with 0.2% Tri-
ton X-100. The activity of β-hexosaminidase in the
medium and within the cells was determined using a
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Fig.　1　Degranulation (a), and luciferase expression (EXiLE) (b) in RS-ATL8 cells sensitized with 
1 : 100-diluted serum and stimulated with 0.1-1000 ng/ml EWE. Measurements were done for 30 
subjects, and representative fi ve (three OFC positives and two negative) subjects (c) are shown. 
Data are represented as fold increase, by taking non-stimulated control as 1.0.
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fluorometric assay with 4-methylumbelliferyl-N-acetyl-
β-D-glucosaminide as a substrate (0.1 mM in 100 mM
citrate, pH 4.5). The reaction was stopped with 0.25-
M glycine buffer after 30-min incubation at 37℃. The
plate was read on a Fluoroskan Ascent plate reader
(Thermo Fisher Scientific, Waltham, MA, USA) using
380-nm excitation and 440-nm emission filters. De-
granulation levels were represented as the fold in-
crease in enzyme activity as follows:
R = 
[(Rsup - blank)/(Rsup - blank + Rppt - blank)]s
[(Rsup - blank)/(Rsup - blank + Rppt - blank)]c
where R is the degranulation level, Rsup the released
enzyme activity in the supernatant, Rppt the residual
enzyme activity within the cell, and blank the buffer
control. Subscripts s and c represent sample and con-
trol (non-stimulated background), respectively. Meas-
urements were done in duplicate, and the average
was used for analysis.
STATISTICAL ANALYSIS
Differences were analyzed using the Mann-Whitney
U test (two-tailed) for unpaired samples. The dis-
criminative usefulness of serum IgE testing methods
was evaluated by constructing ROC curves, where
sensitivity versus 1 - specificity was plotted for each
possible cutoff level, and the area under the curves
(AUCs) was determined. From each ROC curve, we
determined the optimal cutoff range, which was se-
lected at the point closest to the upper-left corner of
the ROC curve and which most efficiently discrimi-
nated between the OFC-positive and negative sub-
jects. The respective sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV) were calculated using Microsoft Excel.
Fisher’s exact probability and logistic regression for-
mula were calculated using R software (ver. 2.9.2).
RESULTS
IgE CROSSLINKING-DEPENDENT DEGRANULA-
TION AND LUCIFERASE EXPRESSION IN RS-
ATL8 CELLS
RS-ATL8 cells were sensitized with 1 : 100-diluted
EW-allergic patients’ sera overnight, and EWE-
induced degranulation and luciferase expression was
measured. Five representative patients’ responses are
shown in Figure 1. To enable comparison, both re-
sponses are presented as the fold increase by taking
the background (non-stimulated) levels as 1.0. As
shown in Figure 1a, degranulation was detected with
serum #1, which contained a high concentration of
EW-specific IgE (48.3 UAml), but no response was
observed when moderate (#2, 9.90 UAml) or low (#3,
3.91 UAml) levels of IgE were used. On the other
hand, the EXiLE test clearly detected mast cell activa-
tion caused by different levels of specific IgE (Fig. 1
b). As expected, the OFC-negative sera (#4, 5) did
not induce any luciferase expression; nevertheless,
serum #4 contained a higher amount of EW-specific
IgE (4.46 UAml) than did the OFC-positive serum
#3. It should be noted that the EXiLE test was per-
formed in a culturing medium supplemented with
10% FCS, which contains a substantial amount of non-
specific proteins.
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Fig.　2　Total IgE (a), EW-specifi c serum IgE (b), degranulation test (c), and EXiLE test (d) in the OFC positive 
and negative subjects. Degranulation and EXiLE tests were performed using RS-ATL8 cells sensitized with 
1 : 100-diluted serum and stimulated with 0.1-1000 ng/ml EWE. The maximum responses in each serum subject 
within the EWE concentration range above are shown. **P < 0.01, ***P < 0.001, Mann-Whitney U test.
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Fig.　3　Area under the ROC curves of EW-specifi c serum IgE (a), degranulation test (b), and EXiLE test 
(c). Conditions are similar to those of Figure 1.
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DIAGNOSTIC ABILITIES OF TOTAL IgE, SPE-
CIFIC IgE, DEGRANULATION, AND EXiLE
A total of 30 patients suspected of having EW allergy
were subjected to an OFC test with boiled egg, and
18 were found to be positive and 12 negative (Table
1). EW-specific IgE was detected in every OFC-
positive subject, i.e., IgE-independent food allergy
subjects were not included in this study. There was
no difference in the total IgE levels in the sera be-
tween OFC-positive and negative patients (Fig. 2a).
On the other hand, EW-specific serum IgE were sig-
nificantly higher (P < 0.0001) in OFC-positive than
negative subjects (Fig. 2b). Both the degranulation
(Fig. 2c) and EXiLE (Fig. 2d) tests were also able to
distinguish between positive and negative subjects
with a significant difference (P = 0.0049 and <0.0001,
respectively).
EVALUATION OF SPECIFIC IgE, DEGRANULA-
TION AND EXiLE TESTS
To evaluate the diagnostic ability of the different in
vitro tests in diagnosing EW allergy, ROC curve
analyses were performed for each test (Fig. 3).13,14
Since RS-ATL8 cells were stimulated with 0.1-1000
ngml EWE in each test, five distinct ROC curves
could be drawn for each concentration in the de-
granulation and EXiLE tests. However, the maximum
response in each subject’s serum within the above
EWE concentration range was considered to be rep-
resentative of the overall response (e.g., the maxi-
mum EXiLE response of #1 in Figure 1b was 8.559 at
1000 ngml). As summarized in Table 2, the AUC of
the ROC curve for the EWE-induced EXiLE test gave
the highest value (0.977), followed by the EW-specific
IgE (0.926) and EWE-induced degranulation tests
(0.810). With the optimal cutoff range obtained from
the ROC curve analyses, sensitivity, specificity, PPV,
NPV, and Fisher’s exact probability were calculated.
Both specificity (0.944) and sensitivity (0.917) were
highest in the EXiLE tests; the CAP-FEIA and de-
granulation tests gave comparable sensitivity and
specificity, though the specificity (0.833) and sensitiv-
ity (0.722), respectively, were lower. PPV (0.944) and
NPV (0.917) were also highest in the EXiLE tests;
Evaluation of the EXiLE Test
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Table　2　Summary of the comparison of three in vitro IgE tests
Test AUC P-value Optimal cutoff range† Sens Spec PPV NPV
Fisher’s exact 
probability
CAP-FEIA (EW) 0.926 <0.0001 3.46-3.91(UA/mL)
0.944 0.833 0.895 0.909 1.548 × 10−5
Degranulation (fold increase)
)l
m/
gn( E
W
E
0.1 0.616 0.2900 1.016-1.117 0.944 0.583 0.773 0.875 0.07172
1 0.764 0.01586 0.839-0.897 0.833 0.583 0.750 0.700 0.04504
10 0.782 0.009842 1.271-1.399 0.667 0.833 0.857 0.625 0.01061
100 0.838 0.002010 1.187-1.219 0.889 0.750 0.842 0.818 0.001221
1000 0.708 0.05684 1.437-1.489 0.667 0.917 0.923 0.647 0.002397
Maximum 0.810 0.004582 1.821-1.860 0.722 0.917 0.929 0.688 7.964 × 10−4
EXiLE (fold increase)
)l
m/
gn( E
W
E
0.1 0.713 0.05155 1.298-1.332 0.611 0.750 0.786 0.563 0.07172
1 0.940 <0.0001 1.217-1.294 1.000 0.917 0.947 1.000 2.197 × 10−7
10 0.972 <0.0001 1.338-1.537 0.944 0.917 0.944 0.917 2.509 × 10−6
100 0.977 <0.0001 1.526-1.765 0.944 0.917 0.944 0.917 2.509 × 10−6
1000 0.958 <0.0001 1.648-1.866 0.944 0.917 0.944 0.917 2.509 × 10−6
Maximum 0.977 <0.0001 1.648-1.876 0.944 0.917 0.944 0.917 2.509 × 10−6
AUC, area under the curve; Sens, sensitivity; Spec, specifi city; PPV, positive predictive value; NPV, negative predictive value.
†Cutoff levels closest to the upper left corner in the ROC curve optimizing both sensitivity and specifi city. Cutoff values between the range 
shown here will give the same prediction results. Sens, Spec, PPV, NPV, and Fisher’s exact probability at the optimal cutoff levels are
shown.
they were moderate in the CAP-FEIA test (0.895 and
0.909, respectively). In the degranulation test, PPV
was very high (0.929), but NPV was relatively low
(0.688).
DISCUSSION
It is well known that antigen-specific IgE in the serum
has good diagnostic usability in distinguishing OFC-
negative and positive subjects with EW allergies.16-18
We found that the optimal cutoff range of EW-specific
IgE determined from ROC curve analysis of CAP-
FEIA was 3.46-3.91 UAml (Table 2), which is slightly
higher than the 2.82 UAmL been reported by Ando
et al. using ROC curve analysis in 108 subjects.15 This
small inconsistency may have arisen from the differ-
ence in populations and their sizes between that
study and the present one.
Conventional degranulation tests based on β-
hexosaminidase release have been widely used to
measure the activation of RBL cell lines19-21 because
of the convenience of such tests compared with other
methods, such as 3H-labeled serotonin release.9,10
However, in measurements of humanized RBL cell
lines, human complements in the serum are cytotoxic
to the rat-derived cells, such that high “spontaneous
release” is observed in the β-hexosaminidase assay,
resulting in a high background with the assay. Figure
1a illustrates that degranulation can be detected with
a relatively high concentration of EW-specific IgE-
containing serum (#1, 48.3 UAml), but not with mod-
erate (#2, 9.90 UAml) or low (#3, 3.91 UAml) levels
of IgE. Regarding OFC-negative subject #4, neither
degranulation nor the EXiLE test detected mast cell
activation, although the EW-specific serum IgE was
4.46 UAml, which is higher than the optimal cutoff
range of CAP-FEIA (Table 2). Considering the high
specificity (0.944) of these tests, it is unsurprising
that clinically irrelevant IgE did not cause mast cell
activation, resulting in negative in these tests. In addi-
tion, this result is consistent with that of our previous
report, which described how clinically irrelevant IgE
bondable to ovomucoid in an outgrown subject could
not activate RS-ATL8 cells.22 To avoid cytotoxicity
due to human complements, serum specimens had to
be diluted to 1 : 100 in the present study. However,
this dilution would seem to be too low to sensitize RS-
ATL8 cells effectively and to detect a marked de-
granulation response, which may have led to the low
sensitivity (0.722) of this test (Table 2). However,
even under these conditions, the specificity (0.917)
and PPV (0.929) were higher than with the CAP-FEIA
test (0.833 and 0.895, respectively) at each optimal
cutoff level.
In the present study, we have shown that the diag-
nostic performance of the EXiLE test was the highest
in the AUC (0.977), sensitivity (0.944), specificity
(0.917), PPV (0.944), NPV (0.917), and Fisher’s exact
probability (2.509 × 10−6) among the three in vitro
IgE tests at each optimal cutoff level (Table 2). Al-
though the highest sensitivity, PPV, and NPV were
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obtained when the cells were stimulated with 1 ngml
of EWE, the optimal cutoff range was very narrow
(1.217-1.294). Therefore, the maximum response
within 0.1-1000 ngml EWE in each subject appears
to be a more reliable and practical indicator for the
EXiLE test. The optimal cutoff range of maximum re-
sponses calculated here was 1.648-1.876, which is
slightly lower than the 2.0 that was taken as the cutoff
level in our previous study.12 When the PPVs were
plotted against the luciferase-expression levels (in
terms of fold increase) in the present study, the logis-
tic regression curve can be drawn using the following
formula:
y = 1[1 + exp (2.7157 - 2.7553x)]
In this formula, 95% PPV is given at a cutoff level of
2.054, which may be used as the level with a 95% pre-
dicted probability of EW allergy.16-18 Meanwhile, 95%
specificity, which is independent of disease preva-
lence and thus may be considered another useful
benchmark,15 is given at a cutoff level of 1.962 from
another regression curve (formula is not shown). Ac-
cordingly, in practice, a twofold increase in luciferase
expression in the EXiLE test seems to be a reason-
able cutoff level for predicting OFC positives.
The BAT based on histamine release6 or CD203c
expression7 is another possible in vitro method for di-
agnosing food allergies without the risk of anaphy-
laxis. When performed in the presence of patient se-
rum, BAT may detect serum-derived factors that
modify the allergic responses, such as neutralizing
antibodies.23 The EXiLE test is also capable of being
performed in the presence of human serum (i.e.,
without washing cells before stimulation); this results
in reduced responses, which may be caused by neu-
tralizing antibodies (unpublished results). In such a
testing situation, however, the maximum concentra-
tion of human serum is 1% because of cytotoxicity12;
with the EXiLE system, this would make it difficult to
fully elucidate the effects of serum factors on allergic
responses. Nevertheless, the BAT requires a whole-
blood specimen, which cannot be preserved for long
periods, and in this context BAT should more cor-
rectly be classified as an ex vivo test rather than an in
vitro test such as CAP-FEIA. Conversely, the EXiLE
test is a bona fide in vitro test, consisting just of the
serum specimen and the cultured mast cell line and
allowing reproducible results to be obtained. Thus,
the EXiLE test is expected to be suitable not only for
diagnosis, but also retrospective epidemiological
studies. Additionally, our preliminary results suggest
that the EXiLE test is so robust that most anti-
allergics, such as disodium cromoglycate and ke-
totifen fumarate, do not affect the results at least until
a concentration of 1 μgml, which is much higher
than the clinical concentration in plasma (data not
shown). Accordingly, unlike with the BAT, it would
not appear necessary to discontinue administering
such anti-allergics before EXiLE testing, which would
be beneficial to the patients.
In conclusion, a luciferase assay-based in vitro elici-
tation test, which measures IgE crosslinking-induced
mast cell activation as an indicator of clinically mean-
ingful serum IgE, would be useful in diagnosing pa-
tients who are suspected of having IgE-dependent
EW allergy without the risk of severe systemic reac-
tions.
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